Metabolic syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
m Robot: Changing Category:Up-To-Date Cardiology to Category:Up-To-Date cardiology |
|||
| (14 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Metabolic syndrome}} | {{Metabolic syndrome}} | ||
{{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com] ; {{ADG}} | |||
{{CMG}}; | |||
==Overview== | ==Overview== | ||
The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of risk factors with [[Diabetes mellitus|diabetes]]. In 1977, Haller coined the term "metabolic syndrome" for the first time when describing the additive effects of risk factors on [[atherosclerosis]]. | |||
==Historical Perspective== | ==Historical Perspective== | ||
The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of risk factors with diabetes | *The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of [[risk factors]] with [[diabetes]].<ref>Joslin EP. The prevention of diabetes mellitus. ''JAMA'' 1921;76:79–84.</ref><ref>Kylin E. [Studies of the hypertension-hyperglycemia-hyperuricemia syndrome] (German). ''Zentralbl Inn Med'' 1923;44: 105-27.</ref> | ||
* | *In 1947, Dr. Jean Vague proposed a theory that upper body [[obesity]] predisposed to [[diabetes]], [[atherosclerosis]], [[gout]], and [[calculi]].<ref>Vague J. La diffférenciacion sexuelle, facteur déterminant des formes de l'obésité. Presse Med 1947;30:339-40.</ref> | ||
* Avogaro, Crepaldi and co-workers | *In 1967, Avogaro, Crepaldi and co-workers discovered obese patients with [[diabetes]], [[hypercholesterolemia]], and marked [[hypertriglyceridemia]] improved when they were put on a hypocaloric, low [[carbohydrate]] diet.<ref>Avogaro P, Crepaldi G, Enzi G, Tiengo A. Associazione di iperlipidemia, diabete mellito e obesità di medio grado. ''Acta Diabetol Lat'' 1967;4:572-590.</ref> | ||
* In 1977, Haller | *In 1977, Haller coined the term "metabolic syndrome" for the first time when describing the additive effects of [[risk factors]] on [[atherosclerosis]].<ref>Haller H. [Epidemiology and associated risk factors of hyperlipoproteinemia] (German). ''Z Gesamte Inn Med'' 1977;32(8):124-8. PMID 883354.</ref> | ||
* | *In 1977, Singer coined the term [[hyperlipoproteinemia]] to describe the associations of [[obesity]], [[gout]], [[diabetes mellitus]], and [[hypertension]] with metabolic syndrome.<ref>Singer P. [Diagnosis of primary hyperlipoproteinemias] (German). ''Z Gesamte Inn Med'' 1977;32(9):129-33. PMID 906591.</ref> | ||
* In 1977 and 1978, Gerald B. Phillips developed the concept that risk factors for myocardial infarction | *In 1977 and 1978, Gerald B. Phillips developed the concept that [[risk factors]] for [[myocardial infarction]] are not only associated with [[heart]] disease, but also with [[aging]], [[obesity]] and other clinical states.<ref>Phillips GB. Sex hormones, risk factors and cardiovascular disease. ''Am J Med'' 1978;65:7-11. PMID 356599.</ref><ref>Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. ''Proc Natl Acad Sci U S A'' 1977;74:1729-1733. PMID 193114.</ref> | ||
* In 1988 | *In 1988, Gerald M. Reaven proposed [[insulin resistance]] as the underlying factor and named the constellation of abnormalities as [[Syndrome X]].<ref>Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. PMID 3056758.</ref> | ||
==References== | ==References== | ||
| Line 30: | Line 22: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Latest revision as of 14:30, 16 October 2017
|
Metabolic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Metabolic syndrome historical perspective |
|
Risk calculators and risk factors for Metabolic syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.B.B.S. [2] ; Aditya Ganti M.B.B.S. [3]
Overview
The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of risk factors with diabetes. In 1977, Haller coined the term "metabolic syndrome" for the first time when describing the additive effects of risk factors on atherosclerosis.
Historical Perspective
- The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of risk factors with diabetes.[1][2]
- In 1947, Dr. Jean Vague proposed a theory that upper body obesity predisposed to diabetes, atherosclerosis, gout, and calculi.[3]
- In 1967, Avogaro, Crepaldi and co-workers discovered obese patients with diabetes, hypercholesterolemia, and marked hypertriglyceridemia improved when they were put on a hypocaloric, low carbohydrate diet.[4]
- In 1977, Haller coined the term "metabolic syndrome" for the first time when describing the additive effects of risk factors on atherosclerosis.[5]
- In 1977, Singer coined the term hyperlipoproteinemia to describe the associations of obesity, gout, diabetes mellitus, and hypertension with metabolic syndrome.[6]
- In 1977 and 1978, Gerald B. Phillips developed the concept that risk factors for myocardial infarction are not only associated with heart disease, but also with aging, obesity and other clinical states.[7][8]
- In 1988, Gerald M. Reaven proposed insulin resistance as the underlying factor and named the constellation of abnormalities as Syndrome X.[9]
References
- ↑ Joslin EP. The prevention of diabetes mellitus. JAMA 1921;76:79–84.
- ↑ Kylin E. [Studies of the hypertension-hyperglycemia-hyperuricemia syndrome] (German). Zentralbl Inn Med 1923;44: 105-27.
- ↑ Vague J. La diffférenciacion sexuelle, facteur déterminant des formes de l'obésité. Presse Med 1947;30:339-40.
- ↑ Avogaro P, Crepaldi G, Enzi G, Tiengo A. Associazione di iperlipidemia, diabete mellito e obesità di medio grado. Acta Diabetol Lat 1967;4:572-590.
- ↑ Haller H. [Epidemiology and associated risk factors of hyperlipoproteinemia] (German). Z Gesamte Inn Med 1977;32(8):124-8. PMID 883354.
- ↑ Singer P. [Diagnosis of primary hyperlipoproteinemias] (German). Z Gesamte Inn Med 1977;32(9):129-33. PMID 906591.
- ↑ Phillips GB. Sex hormones, risk factors and cardiovascular disease. Am J Med 1978;65:7-11. PMID 356599.
- ↑ Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A 1977;74:1729-1733. PMID 193114.
- ↑ Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. PMID 3056758.